Record FY 2025 results with 7% revenue growth and 43.7% higher net profit, driven by a shift to acute and outpatient services. Board recommended 80 million ordinary and 200 million special dividends, with major expansion projects underway.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.